Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ste20-related Proline Alanine Rich Kinase (SPAK) is a serine/threonine kinase that regulates ion transport and cell volume by phosphorylating SLC12A family cation-chloride cotransporters. It is activated by WNK kinases and plays a crucial role in blood pressure regulation and cell volume homeostasis. Dysregulation of SPAK is implicated in hypertension and stroke outcomes. It has emerged as a potential drug target for hypertension and stroke.
Inhibition of SPAK kinase activity to modulate ion transport, particularly sodium and chloride cotransport
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ste20-related Proline Alanine Rich Kinase (SPAK).